ADVANCED WOUND MANAGEMENT

ALGISITE◊ M Calcium Alginate Dressing

A highly absorbent dressing composed of natural, high M-type material,1 shown to absorb excess wound exudate and utilise the benefits of a moist wound environment, which may help prevent eschar formation and promote faster healing.2-6 Suitable for the treatment of pressure injuries or venous leg ulcers with moderate to heavy exudate, or to facilitate the control of minor bleeding*1

AWM-ALGISITE-HERO-840x840-PX.png

Different from other alginates

A unique combination of fibre type and needle bonding process makes ALGISITE M Dressings different from other dressings,1 helping to minimise the shedding of fibres while on the wound and on dressing removal.7

  • Absorbs exudate and forms a gel over the wound surface2,8,9
  • Highly permeable, allowing liquid to evaporate6,10 and permitting gaseous exchange6
  • Allows wound contraction, which may help reduce scarring8,11
ALGISITE-M-web-application.png

Disclaimer

*As demonstrated in vitro.
**n=51.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.

◊Trademark of Smith+Nephew. All trademarks acknowledged. ©2022 Smith+Nephew. All rights reserved.

Citations
  1. Terrill P, et al. Absorption of blood by moist wound healing dressings. Primary Intention - Moist Wound Healing Dressings. 2003;11(1):7 - 17.
  2. Smith+Nephew 2018. Physical property testing of ALGISITE M. Internal Report. U/037/R2.
  3. Brown J, et al. An evidence-based review of split-thickness skin graft donor site dressings. Int Wound J. 2018;15(6):1000 - 1009.
  4. Smith+Nephew 2021. Use of benchtop test data to support product claims for alginate dressings referring to moist wound healing. Internal Report. EO.AWM.PCSgen.009.v1.
  5. Junker J, et al. Clinical Impact Upon Wound Healing and Inflammation in Moist, Wet, and Dry Environments. Adv Wound Caref. 2013;2(7):348 - 356.
  6. Yang Y, et al. Spacer fabric-based exuding wound dressing – Part II: Comparison with commercial wound dressings. Text Res J. 2016;87(12):1481 - 1493.
  7. Smith+Nephew 2018. Fibre shed testing of ALGISITE M. Internal Report. U/037/R1.
  8. Kammerlander G, et al. An assessment of the wound healing properties of Algisite M dressings. Nursing Times. 2003;99(42):54 - 56.
  9. Thomas S. Alginate dressings in surgery and wound management - part 1. J Wound Care. 2000;9(2):56 - 60.
  10. Hasatsri S, et al. Comparison of the Morphological and Physical Properties of Different Absorbent Wound Dressings. Dermatol Res Pract. 2018;11:1 - 6.
  11. Mcbride CA, et al. Prospective randomised controlled trial of Algisite M, Cuticerin, and Sorbact(R) as donor site dressings in paediatric split-thickness skin grafts. Burns Trauma. 2018;6:33.
  12. Smith+Nephew 2000. An in vitro comparison of ALGISITE M versus other alginate dressings, and a hydrofibre dressing, Aquacel. Internal Report. PS/WR/00/05/003a.
  13. Smith+Nephew 2020. PMS 303: ALGISITE M Calcium Alginate Dressing: PMCF Activity Summary Report. Internal Report. EO.AWM.PCS77.001.v1.
  14. Smith+Nephew 2021. PMCF Survey Data for ALGISITE M Calcium Alginate Dressing. Internal Report. EO.AWM.PCS77.002.v1.
  15. Gillman L, et al. A prospective randomised controlled trial of the effectiveness of calcium alginate and retention dressings in split-thickness skin graft donor sites. Wound Practice & Research. 2013;21(4):161 - 169.
  16. Kaiser D, et al. Alginate dressing and polyurethane film versus paraffin gauze in the treatment of split-thickness skin graft donor sites: a randomized controlled pilot study. Adv Skin Wound Care. 2013;26(2):67-73.
  17. Smith+Nephew 2018. Conformability testing of Algisite M. Internal Report. U/037/R7.

Title

Text

Explore